PT
PT Kalbe Farma Tbk.
PTKFF · OTC
$0.05 +0.00% (+$0.00)
Market Cap Rp 41.6T
P/E Ratio 11.50x
Div. Yield 3.99%
ROE 15.22%
Bulios Fair Price
$0.05
4.6% downside
Current Price
$0.052
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTKFF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
94 /100
Cheap P/FCF 16.92x
P/E 11.50x
P/B 1.70x
Growth
36 /100
Stable FCF growth 5.32%
EPS growth 3.46%
Book val. growth 4.57%
Profitability
56 /100
Moderate Op. margin 12.08%
Gross margin 37.15%
FCF margin 6.50%
Quality
78 /100
Excellent ROA 10.85%
ROIC 13.13%
Asset turnover 1.13x
Debt
100 /100
Low Int. coverage 122.42x
Debt/Equity 0.03x
Net debt/EBITDA -0.75x
Stability
84 /100
Stable EPS volatility 19.55%
Beta -0.19x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTKFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bernadette Ruth Irawati Setiady
Employees
12,835
Headquarters
Jakarta
Upcoming events
03 NOV
Earnings
Upcoming earnings report